✦ LIBER ✦

Effectiveness of Switching from a DPP-4 Inhibitor to the Human GLP-1 Analogue Liraglutide in Patients with Type 2 Diabetes

✍ Scribed by Farah, Lucette; Gourdy, Pierre; Charpentier, Guillaume; Martinez, Luc; Eschwege, Eveline; Penfornis, Alfred; Madani, Suliya; Gauthier, Jean-Francois

Book ID: 127262071
Publisher: Canadian Diabetes Association
Year: 2014
Tongue: English
Weight: 50 KB
Volume: 38
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2014.07.127

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of Liraglutide in Type 2 D

Effectiveness of Liraglutide in Type 2 Diabetes Patients Switched from a DPP-4 Inhibitor: 1-Year Data from EVIDENCE®

✍ Charpentier, Guillaume; Martinez, Luc; Eschwege, Eveline; Madani, Suliya; Penfor 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 168 KB

DPP-4 inhibitors and GLP-1 analogues: fo

DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?

✍ S. Halimi 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 451 KB

Liraglutide, a once-daily human GLP-1 an

Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes

✍ Fonseca, V.; Falahati, A.; Zychma, M.; Madsbad, S.; Plutzky, J. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 450 KB

Patient-reported rating of gastrointesti

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

✍ M. Horowitz; T. Vilsbøll; M. Zdravkovic; M. Hammer; S. Madsbad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Efficacy and safety of the once-daily hu

Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes

✍ Seino, Y.; Rasmussen, M.F.; Nishida, T.; Kaku, K. 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 599 KB

The once-daily human GLP-1 analogue lira

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

✍ Flint, A.; Kapitza, C.; Zdravkovic, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB